2021年1月14日 · ARA-290 (a.ka. Cibinetide) is a synthetic peptide developed by Araim Pharmaceuticals that consists of 11 amino acids and is entirely derived from the helix beta domain of erythropoietin (EPO). And in case you don’t know the role of EPO in your body:

2024年11月5日 · ARA-290 is a nonhematopoietic erythropoietin analog that primarily works to improve the symptoms of neuropathic pain. 💉; ARA-290 offers chronic pain relief from diabetic neuropathy, sarcoidosis-induced neuropathic pain, as well as from any tissue injury. 💪

ARA 290, a nonhematopoietic peptide designed from the structure of erythropoietin, interacts selectively with the innate repair receptor that mediates tissue protection. ARA 290 has shown efficacy in preclinical and clinical studies of metabolic control and neuropathy.

2024年11月27日 · ARA 290, also known as cibinetide, is an 11–amino acid peptide that has potent tissue-protective and tissue-regenerative properties. It is called “nonhematopoietic peptide” because ARA 290 exerts its beneficial effects without …

2020年7月1日 · ARA-290, a fragment of EPO, reduced inflamed nerves in an animal study. ARA290 increased angiogenesis, lowers cytokines, TRPV1, apoptosis, and cell adhesion.

ARA 290, a nonhematopoietic peptide designed from the structure of erythropoietin, interacts selectively with the innate repair receptor that mediates tissue protection. ARA 290 has shown efficacy in preclinical and clinical studies of metabolic control and neuropathy.

2024年3月1日 · What is ARA-290? ARA-290, engineered from erythropoietin, is a nonerythropoietic peptide that has shown promise in improving metabolic control and neuropathic symptoms in various studies. Unlike erythropoietin, it specifically activates the innate repair receptor without